Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic apixaban 5 mg vs Eliquis in healthy Thai volunteers (fasting)
TCTR20241015001Phase 1Unknown
- Sponsor
- International Bio Service
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of apixaban in venous thromboembolism (VTE) and Atrial fibrillation (AFib) (2 arms), sponsored by International Bio Service. Status: unknown.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on TCTR20241015001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20241015001.